Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Other Non-Current Assets (2023 - 2025)

Historic Other Non-Current Assets for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $183000.0.

  • Beta Bionics' Other Non-Current Assets rose 8300.0% to $183000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $183000.0, marking a year-over-year increase of 8300.0%. This contributed to the annual value of $5.1 million for FY2024, which is 407438.02% up from last year.
  • Per Beta Bionics' latest filing, its Other Non-Current Assets stood at $183000.0 for Q3 2025, which was up 8300.0% from $144000.0 recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Other Non-Current Assets ranged from a high of $5.1 million in Q4 2024 and a low of $100000.0 during Q1 2024
  • Over the past 3 years, Beta Bionics' median Other Non-Current Assets value was $132500.0 (recorded in 2023), while the average stood at $743125.0.
  • As far as peak fluctuations go, Beta Bionics' Other Non-Current Assets skyrocketed by 407438.02% in 2024, and later soared by 4400.0% in 2025.
  • Beta Bionics' Other Non-Current Assets (Quarter) stood at $121000.0 in 2023, then surged by 4074.38% to $5.1 million in 2024, then plummeted by 96.38% to $183000.0 in 2025.
  • Its last three reported values are $183000.0 in Q3 2025, $144000.0 for Q2 2025, and $146000.0 during Q1 2025.